These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1371571)

  • 1. Beneficial antiarrhythmic effect of beta-blockade in patients with dilated cardiomyopathy.
    Kihara K; Koga Y; Wada T; Toshima H
    Jpn Circ J; 1992 Jan; 56(1):77-85. PubMed ID: 1371571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy--relationship between the effects of antiarrhythmic agents and severity of myocardial lesions.
    Takarada A; Yokota Y; Fukuzaki H
    Jpn Circ J; 1990 Mar; 54(3):260-71. PubMed ID: 2366310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
    Neri R; Mestroni L; Salvi A; Pandullo C; Camerini F
    Am Heart J; 1987 Mar; 113(3):707-15. PubMed ID: 3825860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles underlying the use of Holter monitoring to define the efficacy of antiarrhythmic drugs.
    Moss AJ; Zareba W
    Coron Artery Dis; 1994 Aug; 5(8):665-70. PubMed ID: 8000618
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents].
    Frank R; Raguin D; Tonet J; Fontaine G
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():21-5. PubMed ID: 1726995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy.
    Duffee DF; Shen WK; Smith HC
    Mayo Clin Proc; 1998 May; 73(5):430-3. PubMed ID: 9581582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying ventricular arrhythmias in idiopathic dilated cardiomyopathy: implications for management.
    Merino JL
    Am J Cardiovasc Drugs; 2001; 1(2):105-18. PubMed ID: 14728040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arrhythmogenic potential of cardiomyopathies. Dilated cardiomyopathies].
    Fauchier JP; Cosnay P; Babuty D; Placente M; Rouesnel P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Jan; 84(1):95-103. PubMed ID: 2012491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
    Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
    J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug treatment of chronic ventricular arrhythmia].
    Motté G; Slama M; Dinanian S; Sebag C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():85-9. PubMed ID: 1284883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological therapy of arrhythmias complicating dilated cardiomyopathy--implications of the arrhythmogenic substrate.
    Gumbrielle T; Campbell RW
    Eur Heart J; 1993 Sep; 14 Suppl E():103-6. PubMed ID: 8223746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmia and hemodynamic effects of allapinin during a course therapy in patients with circulatory failure].
    Khodzhakuliev BG; Naumov VG; Blinov SI; Grigor'iants RA
    Kardiologiia; 1992 Apr; 32(4):41-4. PubMed ID: 1405233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of ventricular arrhythmia in idiopathic dilated cardiomyopathy].
    Bolognese L; Totteri A; Skouse D; Di Bello V; Vitali GM; Bianchi C; Ronconi G
    Minerva Cardioangiol; 1986; 34(7-8):469-75. PubMed ID: 3774159
    [No Abstract]   [Full Text] [Related]  

  • 19. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.